A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication ofHelicobacter pylori | Zendy

Sander Veldhuyzen van Zanten | Zendy; Naoki Chiba | Zendy; Alan Barkun | Zendy; Carlo A Fallone | Zendy; Alain Farley | Zendy; Alan Cockeram | Zendy; Chrystian Dallaire | Zendy; Lorinda Simms | Zendy; Barbara Nicholls | Zendy

Open Access

A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication ofHelicobacter pylori

Author(s) -

Sander Veldhuyzen van Zanten,

Naoki Chiba,

Alan Barkun,

Carlo A Fallone,

Alain Farley,

Alan Cockeram,

Chrystian Dallaire,

Lorinda Simms,

Barbara Nicholls

Publication year - 2003

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2003/425293

Subject(s) - clarithromycin , omeprazole , helicobacter pylori , medicine , amoxicillin , gastroenterology , regimen , ranitidine , breath test , intention to treat analysis , ranitidine hydrochloride , randomized controlled trial , antibiotics , chemistry , biochemistry

To assess Helicobacter pylori eradication after one week dual ranitidine bismuth citrate-clarithromycin (RBC-C) or triple omeprazole, clarithromycin and amoxicillin (OCA) therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research